2019

Jin S, Lee WC, Aust D, Pilarsky C, Cordes N. β8 integrin mediates pancreatic cancer cell radiochemoresistance.Mol Cancer Res. 2019 doi: 10.1158/1541-7786.

Vehlow A, Cordes N. DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy.Autophagy. 2019 doi: 10.1080/15548627.2019.1618540

Vehlow A, Klapproth E, Jin S, Hannen R, Hauswald M, Bartsch JW, Nimsky C,
Temme A, Leitinger B, Cordes N. Interaction of Discoidin Domain Receptor 1 with a
14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy Sensitivity.
Cell
Rep. 2019 Mar 26;26(13):3672-3683.e7.

2018

Cordes N, Ney M, Beleites T, Aust D, Baretton G, Thames H, Baumann M, Krause M, Löck S, Appold S Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy  PLoS ONE 13(12): e0209479

Förster S, Hehlgans S, Rödel F, Otto B, Cordes N.Differential effects of α-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells Int J Oncol, 2018

Klapproth E, Dickreuter E, Zakrzewski F, Seifert M, Petzold A, Dahl A, Schröck E, Klink B, Cordes N. Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibitionOncotarget, 2018

2017

Koppenhagen P, Dickreuter E, Cordes N. Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin.Radiother Oncol, 2017

Vehlow A, Klapproth E, Storch K, Dickreuter E, Seifert M, Dietrich A, Bütof  R, Temme A, Cordes N. Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting. Oncotarget, 2017

2016

Eke I, Hehlgans S, Sandfort V, Cordes N. 3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation. Int J Oncol, 2016 

Storch K, Cordes N. The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells.Int J Oncol, 2016

Zscheppang K, Kurth I, Wachtel N, Dubrovska A, Kunz-Schughart L, Cordes N. Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells. J Cancer, 2016

Storch K, Dickreuter E, Artati A, Adamski J, Cordes N. BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage. PLoS One, 2016.

Dickreuter E, Cordes N. The cancer cell adhesion resistome: mechanisms, targeting and translational approaches. Biol Chem, 2016

2015

Eke I, Zscheppang K, Dickreuter E, Hickmann L, Mazzeo E, Unger K, Krause M, Cordes N. Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer.J Natl Cancer Inst, 2015, 107(2)

Storch K, Sagerer A, Cordes N. Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro.Oncol Rep,  Epub 2015 Jan 27

Steglich A, Vehlow A, Eke I, Cordes N. α integrin targeting for radiosensitization of three-dimensionally grown human head and neck squamous cell carcinoma cells.Cancer Lett, 2015, 357(2):542-8

Zienert E, Eke I, Aust D, Cordes N. LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells.Cancer Lett, 2015 Apr 23. [Epub ahead of print]

Rossow L, Eke I, Dickreuter E, Cordes N. Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures.Oncol Rep, 2015

Dickreuter E, Eke I, Krause M, Borgmann K, van Vugt MA, Cordes N. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.Oncogene, 2015

Poschau M, Dickreuter E, Singh-Müller J, Zscheppang K, Eke I, Liersch T, Cordes N. EGFR and β1-integrin targeting differentially affect colorectal carcinoma cell radiosensitivity and invasion.Radiother Oncol, 2015